Xartemis XR oxycodone/acetaminophen regulatory update

Mallinckrodt said FDA extended the PDUFA date by 3 months for an NDA from the company for Xartemis

Read the full 183 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE